• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺功能和临床症状预测 COPD 肺气肿:COSYCONET 研究结果。

Prediction of lung emphysema in COPD by spirometry and clinical symptoms: results from COSYCONET.

机构信息

School of Medicine, Institute of General Practice and Health Services Research, Technische Universität München/Klinikum Rechts der Isar, Orleansstr. 47, 81667, Munich, Germany.

Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, Comprehensive Pneumology Center Munich (CPC-M), Ludwig-Maximilians-Universität München, Ziemssenstr. 1, 80336, Munich, Germany.

出版信息

Respir Res. 2021 Sep 9;22(1):242. doi: 10.1186/s12931-021-01837-2.

DOI:10.1186/s12931-021-01837-2
PMID:
34503520
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8427948/
Abstract

BACKGROUND

Lung emphysema is an important phenotype of chronic obstructive pulmonary disease (COPD), and CT scanning is strongly recommended to establish the diagnosis. This study aimed to identify criteria by which physicians with limited technical resources can improve the diagnosis of emphysema.

METHODS

We studied 436 COPD patients with prospective CT scans from the COSYCONET cohort. All items of the COPD Assessment Test (CAT) and the St George's Respiratory Questionnaire (SGRQ), the modified Medical Research Council (mMRC) scale, as well as data from spirometry and CO diffusing capacity, were used to construct binary decision trees. The importance of parameters was checked by the Random Forest and AdaBoost machine learning algorithms.

RESULTS

When relying on questionnaires only, items CAT 1 & 7 and SGRQ 8 & 12 sub-item 3 were most important for the emphysema- versus airway-dominated phenotype, and among the spirometric measures FEV/FVC. The combination of CAT item 1 (≤ 2) with mMRC (> 1) and FEV/FVC, could raise the odds for emphysema by factor 7.7. About 50% of patients showed combinations of values that did not markedly alter the likelihood for the phenotypes, and these could be easily identified in the trees. Inclusion of CO diffusing capacity revealed the transfer coefficient as dominant measure. The results of machine learning were consistent with those of the single trees.

CONCLUSIONS

Selected items (cough, sleep, breathlessness, chest condition, slow walking) from comprehensive COPD questionnaires in combination with FEV/FVC could raise or lower the likelihood for lung emphysema in patients with COPD. The simple, parsimonious approach proposed by us might help if diagnostic resources regarding respiratory diseases are limited. Trial registration ClinicalTrials.gov, Identifier: NCT01245933, registered 18 November 2010, https://clinicaltrials.gov/ct2/show/record/NCT01245933 .

摘要

背景

肺气肿是慢性阻塞性肺疾病(COPD)的一个重要表型,强烈建议通过 CT 扫描来建立诊断。本研究旨在确定资源有限的医生可以改善肺气肿诊断的标准。

方法

我们研究了来自 COSYCONET 队列的 436 例 COPD 患者的前瞻性 CT 扫描。COPD 评估测试(CAT)和圣乔治呼吸问卷(SGRQ)的所有项目、改良的医学研究委员会(mMRC)量表以及肺活量和 CO 弥散能力的数据均用于构建二叉决策树。参数的重要性通过随机森林和 AdaBoost 机器学习算法进行检查。

结果

仅依靠问卷时,CAT 项目 1 和 7 以及 SGRQ 项目 8 和 12 的第 3 项对于以气腔为主的表型和肺活量测定中的 FEV/FVC 是最重要的。CAT 项目 1(≤2)与 mMRC(>1)和 FEV/FVC 的组合可使肺气肿的可能性增加 7.7 倍。约 50%的患者表现出不会明显改变表型可能性的组合值,这些值在树中很容易识别。CO 弥散能力的纳入显示出转移系数是主要的测量指标。机器学习的结果与单个树的结果一致。

结论

综合 COPD 问卷中的选定项目(咳嗽、睡眠、呼吸困难、胸部状况、行走缓慢)与 FEV/FVC 结合使用,可提高或降低 COPD 患者发生肺肺气肿的可能性。我们提出的这种简单、简约的方法在呼吸系统疾病诊断资源有限的情况下可能会有所帮助。

试验注册

ClinicalTrials.gov,标识符:NCT01245933,于 2010 年 11 月 18 日注册,https://clinicaltrials.gov/ct2/show/record/NCT01245933。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a62/8427948/e39b21c7b098/12931_2021_1837_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a62/8427948/ddceaa73f823/12931_2021_1837_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a62/8427948/5b32654e3d61/12931_2021_1837_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a62/8427948/2cbb5eed50b2/12931_2021_1837_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a62/8427948/e39b21c7b098/12931_2021_1837_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a62/8427948/ddceaa73f823/12931_2021_1837_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a62/8427948/5b32654e3d61/12931_2021_1837_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a62/8427948/2cbb5eed50b2/12931_2021_1837_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a62/8427948/e39b21c7b098/12931_2021_1837_Fig4_HTML.jpg

相似文献

1
Prediction of lung emphysema in COPD by spirometry and clinical symptoms: results from COSYCONET.肺功能和临床症状预测 COPD 肺气肿:COSYCONET 研究结果。
Respir Res. 2021 Sep 9;22(1):242. doi: 10.1186/s12931-021-01837-2.
2
Relationship of spirometric, body plethysmographic, and diffusing capacity parameters to emphysema scores derived from CT scans.肺量计、体描仪和弥散容量参数与 CT 扫描得出的肺气肿评分的关系。
Chron Respir Dis. 2019 Jan-Dec;16:1479972318775423. doi: 10.1177/1479972318775423. Epub 2018 May 9.
3
X-ray dark-field chest imaging for detection and quantification of emphysema in patients with chronic obstructive pulmonary disease: a diagnostic accuracy study.X 射线暗场胸部成像在慢性阻塞性肺疾病患者肺气肿检测和定量中的诊断准确性研究。
Lancet Digit Health. 2021 Nov;3(11):e733-e744. doi: 10.1016/S2589-7500(21)00146-1.
4
The effect of comorbidities on COPD assessment: a pilot study.合并症对慢性阻塞性肺疾病评估的影响:一项试点研究。
Int J Chron Obstruct Pulmon Dis. 2015 Feb 25;10:429-38. doi: 10.2147/COPD.S76124. eCollection 2015.
5
How Common Is Airflow Limitation in Patients With Emphysema on CT Scan of the Chest?胸部CT扫描显示的肺气肿患者气流受限的情况有多常见?
Chest. 2015 Jul;148(1):176-184. doi: 10.1378/chest.14-1556.
6
Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus.非气肿型慢性阻塞性肺疾病与糖尿病有关。
BMC Pulm Med. 2014 Oct 24;14:164. doi: 10.1186/1471-2466-14-164.
7
Single-Breath Simultaneous Measurement of DL and DL as Predictor of the Emphysema Component in COPD - A Retrospective Observational Study.单口气同时测量 DL 和 DL 对 COPD 肺气肿成分的预测作用:一项回顾性观察研究。
Int J Chron Obstruct Pulmon Dis. 2024 Sep 25;19:2123-2133. doi: 10.2147/COPD.S467138. eCollection 2024.
8
Contribution of CT quantified emphysema, air trapping and airway wall thickness on pulmonary function in male smokers with and without COPD.CT定量肺气肿、气体潴留和气道壁厚度对有或无慢性阻塞性肺疾病(COPD)男性吸烟者肺功能的影响。
COPD. 2014 Sep;11(5):503-9. doi: 10.3109/15412555.2014.933952. Epub 2014 Aug 5.
9
Relationships between airflow obstruction and quantitative CT measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary disease.在有和没有慢性阻塞性肺疾病的受试者中,气流阻塞与肺气肿、空气潴留和气道的定量 CT 测量之间的关系。
AJR Am J Roentgenol. 2013 Sep;201(3):W460-70. doi: 10.2214/AJR.12.10102.
10
Relationship Between Emphysema Severity and the Location of Lung Cancer in Patients With Chronic Obstructive Lung Disease.慢性阻塞性肺疾病患者肺气肿严重程度与肺癌位置的关系
AJR Am J Roentgenol. 2015 Sep;205(3):540-5. doi: 10.2214/AJR.14.13992.

引用本文的文献

1
Unravelling the Information Contained in the Single Items of the COPD Assessment Test for Different Outcomes and Smoking Status in Patients with COPD: Results from COSYCONET.解读慢性阻塞性肺疾病评估测试单项内容中关于慢性阻塞性肺疾病患者不同结局及吸烟状况的信息:COSYCONET研究结果
Int J Chron Obstruct Pulmon Dis. 2024 Dec 5;19:2629-2638. doi: 10.2147/COPD.S475112. eCollection 2024.
2
Interaction between CD244 and SHP2 regulates inflammation in chronic obstructive pulmonary disease via targeting the MAPK/NF-κB signaling pathway.CD244 与 SHP2 相互作用通过靶向 MAPK/NF-κB 信号通路调节慢性阻塞性肺疾病中的炎症反应。
PLoS One. 2024 Oct 18;19(10):e0312228. doi: 10.1371/journal.pone.0312228. eCollection 2024.
3

本文引用的文献

1
Metformin: Experimental and Clinical Evidence for a Potential Role in Emphysema Treatment.二甲双胍:在肺气肿治疗中具有潜在作用的实验和临床证据。
Am J Respir Crit Care Med. 2021 Sep 15;204(6):651-666. doi: 10.1164/rccm.202012-4510OC.
2
Relationship between clinical and radiological signs of bronchiectasis in COPD patients: Results from COSYCONET.COPD 患者支气管扩张的临床和影像学征象之间的关系:来自 COSYCONET 的结果。
Respir Med. 2020 Oct;172:106117. doi: 10.1016/j.rmed.2020.106117. Epub 2020 Aug 22.
3
Capnovolumetry in combination with clinical history for the diagnosis of asthma and COPD.
How do deep-learning models generalize across populations? Cross-ethnicity generalization of COPD detection.
深度学习模型如何在不同人群中进行泛化?慢性阻塞性肺疾病检测的跨种族泛化。
Insights Imaging. 2024 Aug 7;15(1):198. doi: 10.1186/s13244-024-01781-x.
4
Effects of triple therapy on disease burden in patients of GOLD groups C and D: results from the observational COPD cohort COSYCONET.三联疗法对 GOLD 分组 C 和 D 患者疾病负担的影响:COSYCONET 观察性 COPD 队列研究结果。
BMC Pulm Med. 2024 Mar 1;24(1):103. doi: 10.1186/s12890-024-02902-4.
5
Role of thioredoxin in chronic obstructive pulmonary disease (COPD): a promising future target.硫氧还蛋白在慢性阻塞性肺疾病(COPD)中的作用:一个有前途的未来靶点。
Respir Res. 2023 Nov 24;24(1):295. doi: 10.1186/s12931-023-02574-4.
6
Impulse Oscillometry as a Diagnostic Test for Pulmonary Emphysema in a Clinical Setting.脉冲振荡法在临床环境中作为肺气肿诊断试验的应用
J Clin Med. 2023 Feb 15;12(4):1547. doi: 10.3390/jcm12041547.
7
Standardized airway wall thickness Pi10 from routine CT scans of COPD patients as imaging biomarker for disease severity, lung function decline, and mortality.COPD 患者常规 CT 扫描的标准化气道壁厚度 Pi10 作为疾病严重程度、肺功能下降和死亡率的影像学生物标志物。
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666221148663. doi: 10.1177/17534666221148663.
8
[What have we learned from the German COPD cohort COSYCONET and where do we go from here?].[我们从德国慢性阻塞性肺疾病队列研究COSYCONET中学到了什么,以及我们从这里将走向何方?]
Pneumologie. 2023 Feb;77(2):81-93. doi: 10.1055/a-1966-0848. Epub 2022 Dec 16.
容积描记法结合临床病史用于哮喘和 COPD 的诊断。
NPJ Prim Care Respir Med. 2020 Jul 30;30(1):32. doi: 10.1038/s41533-020-00190-z.
4
CAT score single item analysis in patients with COPD: Results from COSYCONET.COPD 患者 CAT 评分单项分析:来自 COSYCONET 的结果。
Respir Med. 2019 Nov;159:105810. doi: 10.1016/j.rmed.2019.105810. Epub 2019 Nov 7.
5
Relationship of spirometric, body plethysmographic, and diffusing capacity parameters to emphysema scores derived from CT scans.肺量计、体描仪和弥散容量参数与 CT 扫描得出的肺气肿评分的关系。
Chron Respir Dis. 2019 Jan-Dec;16:1479972318775423. doi: 10.1177/1479972318775423. Epub 2018 May 9.
6
Official ERS technical standards: Global Lung Function Initiative reference values for the carbon monoxide transfer factor for Caucasians.官方 ERS 技术标准:高加索人群一氧化碳传递因子的全球肺功能倡议参考值。
Eur Respir J. 2017 Sep 11;50(3). doi: 10.1183/13993003.00010-2017. Print 2017 Sep.
7
: adjust for lung volume, standardised reporting and interpretation.针对肺容量进行调整、标准化报告及解读。
Eur Respir J. 2017 Aug 24;50(2). doi: 10.1183/13993003.01144-2017. Print 2017 Aug.
8
Endoscopic Lung Volume Reduction: An Expert Panel Recommendation - Update 2017.内镜肺减容术:专家小组建议-2017 年更新。
Respiration. 2017;94(4):380-388. doi: 10.1159/000479379. Epub 2017 Aug 18.
9
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.慢性阻塞性肺疾病全球策略:诊断、管理与预防 2017 年报告。GOLD 执行摘要。
Am J Respir Crit Care Med. 2017 Mar 1;195(5):557-582. doi: 10.1164/rccm.201701-0218PP.
10
Emphysema- and airway-dominant COPD phenotypes defined by standardised quantitative computed tomography.通过标准化定量计算机断层扫描定义的肺气肿和气道为主的 COPD 表型。
Eur Respir J. 2016 Jul;48(1):92-103. doi: 10.1183/13993003.01878-2015. Epub 2016 May 26.